Arvind Shinde on Using Fitness Trackers to Monitor Patients With Cancer
Arvind Shinde, MD, MBA, MPH, assistant clinical professor at Cedars-Sinai Medical Center, discusses the potential benefits of monitoring patients with fitness trackers.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
